ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Lixte Biotechnology Holdings Inc

Lixte Biotechnology Holdings Inc (LIXT)

1,20
0,09
(8,11%)
Geschlossen 13 März 9:00PM
1,20
0,00
( 0,00% )
Vor Marktöffnung: 9:00AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
1,20
Gebot
1,20
Fragen
1,47
Volumen
-
0,00 Tagesbereich 0,00
1,02 52-Wochen-Bereich 4,40
Marktkapitalisierung
Handelsende
1,20
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
68.330
Ausgegebene Aktien
2.249.290
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,53
Gewinn pro Aktie (EPS)
-2,26
Erlöse
-
Nettogewinn
-5,09M

Über Lixte Biotechnology Holdings Inc

Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies ar... Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Lixte Biotechnology Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LIXT. The last closing price for Lixte Biotechnology was US$1,20. Over the last year, Lixte Biotechnology shares have traded in a share price range of US$ 1,02 to US$ 4,40.

Lixte Biotechnology currently has 2.249.290 shares in issue. The market capitalisation of Lixte Biotechnology is US$2,70 million. Lixte Biotechnology has a price to earnings ratio (PE ratio) of -0.53.

LIXT Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.010.8403361344541.191.271.02274231.16252822CS
4-0.21-14.89361702131.411.551.02336101.31689166CS
12-0.75-38.46153846151.9531.02683301.92138477CS
26-0.8-40231.023276272.04896265CS
52-1.18-49.57983193282.384.41.023166272.67526988CS
156-11.9-90.839694656513.149.51.0256022213.6589839CS
260-37.3-96.883116883138.571.91.0262591220.38679464CS

LIXT - Frequently Asked Questions (FAQ)

What is the current Lixte Biotechnology share price?
The current share price of Lixte Biotechnology is US$ 1,20
How many Lixte Biotechnology shares are in issue?
Lixte Biotechnology has 2.249.290 shares in issue
What is the market cap of Lixte Biotechnology?
The market capitalisation of Lixte Biotechnology is USD 2,7M
What is the 1 year trading range for Lixte Biotechnology share price?
Lixte Biotechnology has traded in the range of US$ 1,02 to US$ 4,40 during the past year
What is the PE ratio of Lixte Biotechnology?
The price to earnings ratio of Lixte Biotechnology is -0,53
What is the reporting currency for Lixte Biotechnology?
Lixte Biotechnology reports financial results in USD
What is the latest annual profit for Lixte Biotechnology?
The latest annual profit of Lixte Biotechnology is USD -5,09M
What is the registered address of Lixte Biotechnology?
The registered address for Lixte Biotechnology is 108 WEST, 13TH ST, WILMINGTON, DELAWARE, 19801
What is the Lixte Biotechnology website address?
The website address for Lixte Biotechnology is lixte.com
Which industry sector does Lixte Biotechnology operate in?
Lixte Biotechnology operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDUSRadius Recycling Inc
US$ 28,51
(108,71%)
25,55k
AAOIApplied Optoelectronics Inc
US$ 25,10
(58,16%)
260,77k
BTOGBit Origin Ltd
US$ 0,424
(55,37%)
19,16M
MRMMEDIROM Healthcare Technologies Inc
US$ 0,918
(48,06%)
2,49M
CLLSCellectis SA
US$ 1,80
(39,53%)
3,45M
TLFTandy Leather Factory Inc
US$ 2,01
(-32,55%)
1
CEADCEA Industries Inc
US$ 6,01
(-30,12%)
3
YMABY mAbs Therapeutics Inc
US$ 3,41
(-27,91%)
1
MKZRMackenzie Realty Capital Inc
US$ 1,55
(-22,11%)
2
ELVNEnliven Therapeutics Inc
US$ 16,20
(-20,16%)
123
BTOGBit Origin Ltd
US$ 0,424
(55,37%)
19,16M
DGLYDigital Ally Inc
US$ 0,0909
(14,48%)
12,97M
ADTXAditxt Inc
US$ 0,0344
(2,99%)
5,35M
SHViShares Short Treasury Bond ETF
US$ 110,28
(0,04%)
4,47M
CLLSCellectis SA
US$ 1,80
(39,53%)
3,45M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen